Developer docs
API playgroundTry for free, no card

Search company profiles

Brainjo

Full company profile

uuid000c75b

Namestring
Brainjo
Legal namestring
brainjo GmbH
Websiteurl
brainjo.de
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Brainjo (legal entity brainjo GmbH) is a Regensburg, Germany-based digital health company founded in 2020 as a spin-out of Ostbayerische Technische Hochschulen (OTH Regensburg). It develops VR-based digital therapeutics (DTx) delivered through Meta Quest 2 hardware, with a lead product BJ-101 VR HyperHero — a 24-session, 5-module, 3-month gamified VR therapy for children aged 8-13 with ADHD, built on evidence-based psychotherapy content adapted with key opinion leaders Prof. Dr. Manfred Döpfner and Prof. Dr. Anja Görtz-Dorten of the AKiP Institute at the University of Cologne. The company is pursuing German DiGA (Digital Health Application) approval with planned market entry in 2028 and a target reimbursement price of approximately €250 per prescription covered by statutory health insurers.

The business is built around two complementary revenue tracks. The regulated DTx track bundles BJ-101 ADHD and a pipeline of eight additional candidates spanning phobias, hearing loss, depression, childhood obesity, autism, cognitive decline, chronic pain, and dialysis-related cognitive decline (BJ-102 through BJ-109), supported by a strategic co-development partnership with MEDICE – The Health Family and clinical study infrastructure targeting a 2025 study start. The corporate health track sells VR BOX (portable case-based) and VR HUB (stationary touchscreen kiosk) hardware alongside VR brain-training applications, 10-week mental fitness programs, and on-site Health Day events priced at €1,499.96, with reimbursement pathways via German health insurers under §20 SGB V. Go-to-market mixes direct enterprise field sales to German corporations for BGM (Betriebliches Gesundheitsmanagement), clinical/hospital distribution pending DiGA listing, community-led engagement through a WhatsApp-based ADHD family community of 70+ families, and event-driven demand generation at trade fairs and corporate health days.

The company is venture-backed by HTGF High-Tech Gründerfonds (lead investor across both rounds), MEDICE – The Health Family, and angel investors from better ventures, with total disclosed equity and grant funding exceeding €3.7 million (€1.05M pre-seed + €650K European/state grants in early 2024; €2M seed in April 2026). Brainjo employs 11-13 people across VR development, game design, product/regulatory, legal, and management functions, supplemented by an advisory board spanning DTx commercialization (ex-Kaia Health), digital health consulting (_fbeta), neurotechnology (g.tec), gaming production (ex-Warner Bros. Games/Disney), and Meta public policy.

Short descriptiontext

Brainjo is a Regensburg, Germany-based digital health company developing VR-based digital therapeutics, with its lead product BJ-101 VR HyperHero targeting children aged 8-13 with ADHD. It pursues German DiGA reimbursement (planned for 2028) and additionally sells VR BOX and VR HUB hardware for corporate workplace wellness programs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRegensburg, Germany
HQ citystring
Regensburg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
VR digital therapeutics, ADHD therapy software, corporate wellness VR, digital health applications, VR cognitive training
Industry1 code
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code2 codes
  • Research and Development in the Social Sciences and Humanities54172
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming Services7371
Product category
Digital Therapeutics
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1VR BOX and VR HUB Hardware Sales
TypeHardware Sales
Description

Sale/rental of VR hardware packages including Meta Quest 2 headsets in portable cases (VR BOX) or fixed stations (VR HUB). VR BOX from 3-month rental contracts; VR HUB available for on-site corporate use.

brainjo.de
2Health Day Events
TypeProfessional Services
Description

Corporate health day events at €1,499.96, including VR training sessions, expert consultation, and personalized 10-week exercise plans. Can serve 30-40 participants per day with health insurance reimbursement possible.

brainjo.de
3Enterprise Software Subscriptions
TypeSubscription Recurring
Description

Enterprise tier includes 10-week Mental Fit Program with progress tracking, competition and motivation app. Individual tier offers custom VR application development from €3,000.

brainjo.de
4DiGA (Digital Health Application) Revenue
TypeSubscription Recurring
Description

Planned reimbursement through German health insurance (Krankenkassen) for VR-based digital therapeutics. Estimated cost of approximately €250 per prescription for anxiety disorders DiGA. Market approval planned for 2028.

eu-startups.com
5Corporate Health BGM Programs
TypeSubscription Recurring
Description

Ongoing corporate wellness programs combining cognitive training with physical exercises for employee mental fitness. Funded through health insurance cooperation under §20 SGB V.

brainjo.de
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations
Pricing details6 tiers
1Health Day corporate event package
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

€1,499.96 per event (suggested retail €2,000). Includes VR training, expert consultation, personalized 10-week exercise plans. Reimbursement possible through health insurance.

brainjo.de
2VR BOX hardware package
ModelSubscriptionBilling cadenceMulti-year contract
Notes

From 3-month contract term. Refund available if cancelled more than 3 weeks before delivery. Includes Meta Quest 2 headset, app access, manuals, and promotional posters. Currently 50 units available.

brainjo.de
3Basic subscription tier
ModelSubscriptionBilling cadenceMonthly
Notes

6 cognitive exercises included. Order via email.

brainjo.de
4Enterprise subscription tier
ModelSubscriptionBilling cadenceAnnual
Notes

10-week Mental Fit Program with efficient progress tracking and competition/motivation app.

brainjo.de
5Individual custom development
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Individually customized VR application for better transfer effect. Development starting from €3,000 one-time.

brainjo.de
6Anxiety Disorder DiGA (planned)
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Target price approximately €250 per prescription covered by German health insurance. VR headsets would be loaned to patients.

brainjo.de
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Core offering1 text field

Brainjo develops VR-based digital therapeutics (DTx) — primarily the BJ-101 VR HyperHero program for children with ADHD (aged 8-13), with a pipeline of nine therapeutic candidates spanning phobias, depression, hearing loss, obesity, autism, cognitive decline, chronic pain and dialysis-related cognitive decline. In parallel, the company runs a Corporate Health division that sells VR BOX and VR HUB hardware bundles, delivers on-site corporate Health Day events, and licenses a 10-week Mental Fit corporate brain-training program combining cognitive and physical exercises.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 10-minute brain training burns approximately 148 calories at over 80% of maximum heart rate (aerobic training zone)
+5 more records
Product overview1 text field

Brainjo is a digital health platform offering VR-based digital therapeutics (DTx) through a pipeline of therapeutic candidates targeting various conditions. The core products include BJ-101 VR HyperHero for ADHD in children (the lead product in clinical development) and additional VR therapies for phobias, depression, childhood obesity, autism, cognitive decline, chronic pain, and dialysis complications in various development stages. The company also offers a Corporate Health division with VR BOX and VR HUB hardware products for workplace wellness, including brain training applications, mindfulness programs, and corporate health day events. All therapeutic products aim for DiGA (Digital Health Application) approval for health insurance reimbursement in Germany.

Product and service6 records
1BJ-101 VR HyperHero
CategoryDigital Therapeutics (DiGA)
Description

VR-based digital therapy application for children with ADHD aged 8-13, consisting of 5 modules across 24 sessions (~40 min each) over approximately 3 months. Delivers evidence-based psychotherapy through gamified immersive VR worlds, co-developed with key ADHD opinion leaders and aimed at DiGA reimbursement.

2BJ-102 VR Phobien
CategoryDigital Therapeutics (DiGA)
Description

VR-based DiGA for treatment of anxiety disorders and phobias using evidence-based behavioral therapy with exposure elements; targeted for ICD-10 conditions F40.0, F40.1 and F40.2, with planned 100% German health-insurance reimbursement.

3VR BOX
CategoryHardware
Description

Mobile VR solution packaged in a portable stainless-steel case containing a Meta Quest 2 headset with controller, app access, manuals and posters; sold or rented from 3-month contract terms for decentralized corporate health, trade shows and gymnasiums.

4VR HUB
CategoryHardware
Description

Stationary VR station with a 15-inch touchscreen display on Android OS, Meta Quest 2 headset with magnetic charging, and mobile design on casters; intended for on-site use in companies, fitness studios and hotels.

5Corporate Health Applications
CategoryCorporate Wellness Software
Description

Suite of VR applications for corporate health management combining cognitive tasks with physical exercises; includes a 10-week mindfulness program, plus memory, reaction, decision-making, movement-memory, hand-eye coordination and spatial-reasoning exercises.

6Gesundheitstag (Health Day)
CategoryCorporate Health Services
Description

On-site corporate health day event featuring ~10-minute VR brain-training sessions per participant, consultation with psychologists and sports scientists, a personalized 10-week exercise plan and individual training folders; priced at €1,499.96 per event with up to 100% reimbursement via German §20 SGB V health-insurance funding.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1MEDICE – The Health Family
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Co-development partner for BJ-101 VR HyperHero ADHD DiGA. Strategic collaboration to bring VR-based ADHD therapy to market with pharmaceutical industry expertise and market access.

brainjo.de
Strategic tierCoreTypeStrategic or Co-development Partner
Description

University spin-out origin. brainjo was founded from OTH Regensburg and an ADHD initiative, maintaining ongoing research relationships with the university.

3Prof. Dr. Anja Görtz-Dorten
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading ADHD Key Opinion Leader (KOL) and Head of AKiP Institute at University of Cologne. Collaborated on evidence-based content development for VR ADHD therapy, adapting therapy manuals for immersive VR experience.

brainjo.de
4Prof. Dr. Manfred Döpfner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Former Head of AKiP Institute at University of Cologne, psychologist, psychotherapist, and author. Collaborated on evidence-based content development for VR ADHD therapy.

brainjo.de
5Fernuniversität Hagen
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaboration on BJ-103 VR Cochlea project for inner ear hearing loss treatment using VR technology.

brainjo.de
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Digital health consulting partner. Jonas Albert, Partner at fbeta, serves on advisory board with expertise in DiGA/DiPA market. Member of DTx Consulting Alliance.

7Kinder- und Jugendhilfe Regensburg
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Child and youth welfare organization in Regensburg. Clinical psychologist Julia Punk collaborates on therapy development and provides practical feedback from therapy settings.

brainjo.de
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Gaming expertise collaboration. Timothy Johnson, ex-Technical Director at WB Games (Harry Potter), Disney, serves as gaming expert on advisory board to ensure engaging gamification.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Selfapy is a Berlin-based DTx provider with DiGA-listed courses for depression, burnout and anxiety. It is a regional German competitor in the digital mental health reimbursement space adjacent to Brainjo's BJ-101, BJ-102 and BJ-104 assets.

TypeRegional player
Description

HelloBetter (formerly GET.ON) is a German digital therapeutics company with multiple DiGA-listed products for mental health. It is a direct regional peer in the German DiGA mental health category and a key competitor for physician adoption and reimbursement positioning.

TypeDirect peer
Description

BehaVR develops immersive VR-based digital therapeutics for behavioral and mental health conditions (anxiety, chronic pain, oncology support). It is a direct peer in VR-DTx modality and overlaps with Brainjo's anxiety (BJ-102) and chronic pain (BJ-108) pipeline assets.

TypeDirect peer
Description

Kaia Health is a digital therapeutics company with DiGA-listed products in Germany for MSK pain and COPD. Advisory board member Dr. Stephan Huber is a former Kaia Health DTx expert, making Kaia both a direct DTx peer in Germany and an important prior employer signaling industry credibility.

TypeBroad incumbent
Description

Big Health (Sleepio, Daylight) is a leading digital therapeutics company for insomnia and anxiety. It is a broader incumbent in prescription DTx for behavioral health and represents the scale-of-ambition benchmark Brainjo is targeting with its ADHD and anxiety assets.

TypeDirect peer
Description

Akili Interactive is a digital therapeutics company with an FDA-cleared prescription video game treatment (EndeavorRx) for pediatric ADHD. It is the closest direct competitor to Brainjo's BJ-101 VR HyperHero in indication, modality and patient age range, and represents the regulatory and commercial benchmark Brainjo is targeting via the DiGA pathway.

7XRHealth
TypeDirect peer
Description

XRHealth operates a VR-based telehealth platform delivering clinician-supervised therapy for anxiety, ADHD, cognitive rehabilitation and pain — directly overlapping with Brainjo's clinical use cases and VR-modality approach.

TypeBroad incumbent
Description

Limbic is a UK-based digital mental health platform with AI-driven support and is exploring VR-supported therapy. It is a broader incumbent in the European digital behavioral health space overlapping with Brainjo's BJ-101 and BJ-102.

TypeBroad incumbent
Description

MindMaze is a Swiss-based neurotechnology company building VR-based digital therapeutics for neurological and behavioral conditions. It is a broader incumbent in VR-DTx with significantly more capital and a multi-indication platform analogous to Brainjo's ambition.

TypeDirect peer
Description

Sympatient is a German startup offering VR-based exposure therapy for anxiety disorders and phobias, and is a DiGA-listed competitor. It is a direct regional peer to Brainjo's BJ-102 VR Phobien anxiety product in the German payer market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Brainjo

Digital Therapeuticsbrainjo.de

Brainjo is a Regensburg, Germany-based digital health company developing VR-based digital therapeutics, with its lead product BJ-101 VR HyperHero targeting children aged 8-13 with ADHD. It pursues German DiGA reimbursement (planned for 2028) and additionally sells VR BOX and VR HUB hardware for corporate workplace wellness programs.

What Brainjo does

Brainjo (legal entity brainjo GmbH) is a Regensburg, Germany-based digital health company founded in 2020 as a spin-out of Ostbayerische Technische Hochschulen (OTH Regensburg). It develops VR-based digital therapeutics (DTx) delivered through Meta Quest 2 hardware, with a lead product BJ-101 VR HyperHero — a 24-session, 5-module, 3-month gamified VR therapy for children aged 8-13 with ADHD, built on evidence-based psychotherapy content adapted with key opinion leaders Prof. Dr. Manfred Döpfner and Prof. Dr. Anja Görtz-Dorten of the AKiP Institute at the University of Cologne. The company is pursuing German DiGA (Digital Health Application) approval with planned market entry in 2028 and a target reimbursement price of approximately €250 per prescription covered by statutory health insurers.

The business is built around two complementary revenue tracks. The regulated DTx track bundles BJ-101 ADHD and a pipeline of eight additional candidates spanning phobias, hearing loss, depression, childhood obesity, autism, cognitive decline, chronic pain, and dialysis-related cognitive decline (BJ-102 through BJ-109), supported by a strategic co-development partnership with MEDICE – The Health Family and clinical study infrastructure targeting a 2025 study start. The corporate health track sells VR BOX (portable case-based) and VR HUB (stationary touchscreen kiosk) hardware alongside VR brain-training applications, 10-week mental fitness programs, and on-site Health Day events priced at €1,499.96, with reimbursement pathways via German health insurers under §20 SGB V. Go-to-market mixes direct enterprise field sales to German corporations for BGM (Betriebliches Gesundheitsmanagement), clinical/hospital distribution pending DiGA listing, community-led engagement through a WhatsApp-based ADHD family community of 70+ families, and event-driven demand generation at trade fairs and corporate health days.

The company is venture-backed by HTGF High-Tech Gründerfonds (lead investor across both rounds), MEDICE – The Health Family, and angel investors from better ventures, with total disclosed equity and grant funding exceeding €3.7 million (€1.05M pre-seed + €650K European/state grants in early 2024; €2M seed in April 2026). Brainjo employs 11-13 people across VR development, game design, product/regulatory, legal, and management functions, supplemented by an advisory board spanning DTx commercialization (ex-Kaia Health), digital health consulting (_fbeta), neurotechnology (g.tec), gaming production (ex-Warner Bros. Games/Disney), and Meta public policy.

Brainjo firmographics

Firmographics
Name
Brainjo
Legal name
brainjo GmbH
Website
https://brainjo.de
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Brainjo is a Regensburg, Germany-based digital health company developing VR-based digital therapeutics, with its lead product BJ-101 VR HyperHero targeting children aged 8-13 with ADHD. It pursues German DiGA reimbursement (planned for 2028) and additionally sells VR BOX and VR HUB hardware for corporate workplace wellness programs.
Ownership category
akta.pro rank

Brainjo industry classification

Industry
Product category
Digital Therapeutics
NAICS
Research and Development in the Social Sciences and Humanities (54172), Scientific Research and Development Services (5417)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming Services (7371)
akta.pro industry
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • VR digital therapeutics
  • ADHD therapy software
  • Corporate wellness VR
  • Digital health applications
  • VR cognitive training

Where Brainjo is headquartered

Location

Headquarters

HQ city
Regensburg
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Brainjo business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations

Revenue model

  1. VR BOX and VR HUB Hardware Sales: Sale/rental of VR hardware packages including Meta Quest 2 headsets in portable cases (VR BOX) or fixed stations (VR HUB). VR BOX from 3-month rental contracts; VR HUB available for on-site corporate use.
  2. Health Day Events: Corporate health day events at €1,499.96, including VR training sessions, expert consultation, and personalized 10-week exercise plans. Can serve 30-40 participants per day with health insurance reimbursement possible.
  3. Enterprise Software Subscriptions: Enterprise tier includes 10-week Mental Fit Program with progress tracking, competition and motivation app. Individual tier offers custom VR application development from €3,000.
  4. DiGA (Digital Health Application) Revenue: Planned reimbursement through German health insurance (Krankenkassen) for VR-based digital therapeutics. Estimated cost of approximately €250 per prescription for anxiety disorders DiGA. Market approval planned for 2028.
  5. Corporate Health BGM Programs: Ongoing corporate wellness programs combining cognitive training with physical exercises for employee mental fitness. Funded through health insurance cooperation under §20 SGB V.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goHealth Day corporate event package
SubscriptionMulti-year contractVR BOX hardware package
SubscriptionMonthlyBasic subscription tier
SubscriptionAnnualEnterprise subscription tier
One time/ perpetual licensePay-as-you-goIndividual custom development
SubscriptionMulti-year contractAnxiety Disorder DiGA (planned)

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Brainjo product offering

Product offering

Core offering

Brainjo develops VR-based digital therapeutics (DTx) — primarily the BJ-101 VR HyperHero program for children with ADHD (aged 8-13), with a pipeline of nine therapeutic candidates spanning phobias, depression, hearing loss, obesity, autism, cognitive decline, chronic pain and dialysis-related cognitive decline. In parallel, the company runs a Corporate Health division that sells VR BOX and VR HUB hardware bundles, delivers on-site corporate Health Day events, and licenses a 10-week Mental Fit corporate brain-training program combining cognitive and physical exercises.

Product overview

Brainjo is a digital health platform offering VR-based digital therapeutics (DTx) through a pipeline of therapeutic candidates targeting various conditions. The core products include BJ-101 VR HyperHero for ADHD in children (the lead product in clinical development) and additional VR therapies for phobias, depression, childhood obesity, autism, cognitive decline, chronic pain, and dialysis complications in various development stages. The company also offers a Corporate Health division with VR BOX and VR HUB hardware products for workplace wellness, including brain training applications, mindfulness programs, and corporate health day events. All therapeutic products aim for DiGA (Digital Health Application) approval for health insurance reimbursement in Germany.

Differentiator

Problem solved

Functional benefit

Products and services

  • BJ-101 VR HyperHero VR-based digital therapy application for children with ADHD aged 8-13, consisting of 5 modules across 24 sessions (~40 min each) over approximately 3 months. Delivers evidence-based psychotherapy through gamified immersive VR worlds, co-developed with key ADHD opinion leaders and aimed at DiGA reimbursement.
  • BJ-102 VR Phobien VR-based DiGA for treatment of anxiety disorders and phobias using evidence-based behavioral therapy with exposure elements; targeted for ICD-10 conditions F40.0, F40.1 and F40.2, with planned 100% German health-insurance reimbursement.
  • VR BOX Mobile VR solution packaged in a portable stainless-steel case containing a Meta Quest 2 headset with controller, app access, manuals and posters; sold or rented from 3-month contract terms for decentralized corporate health, trade shows and gymnasiums.
  • VR HUB Stationary VR station with a 15-inch touchscreen display on Android OS, Meta Quest 2 headset with magnetic charging, and mobile design on casters; intended for on-site use in companies, fitness studios and hotels.
  • Corporate Health Applications Suite of VR applications for corporate health management combining cognitive tasks with physical exercises; includes a 10-week mindfulness program, plus memory, reaction, decision-making, movement-memory, hand-eye coordination and spatial-reasoning exercises.
  • Gesundheitstag (Health Day) On-site corporate health day event featuring ~10-minute VR brain-training sessions per participant, consultation with psychologists and sports scientists, a personalized 10-week exercise plan and individual training folders; priced at €1,499.96 per event with up to 100% reimbursement via German §20 SGB V health-insurance funding.

Quantifiable outcome

  • 10-minute brain training burns approximately 148 calories at over 80% of maximum heart rate (aerobic training zone)
  • +5 more outcomes

Companies that use Brainjo

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Brainjo technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Brainjo partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • MEDICE – The Health FamilycoreStrategic or Co-development PartnerCo-development partner for BJ-101 VR HyperHero ADHD DiGA. Strategic collaboration to bring VR-based ADHD therapy to market with pharmaceutical industry expertise and market access.
  • Ostbayerische Technische Hochschulen (OTH Regensburg)coreStrategic or Co-development PartnerUniversity spin-out origin. brainjo was founded from OTH Regensburg and an ADHD initiative, maintaining ongoing research relationships with the university.
  • Prof. Dr. Anja Görtz-DortencoreStrategic or Co-development PartnerLeading ADHD Key Opinion Leader (KOL) and Head of AKiP Institute at University of Cologne. Collaborated on evidence-based content development for VR ADHD therapy, adapting therapy manuals for immersive VR experience.
  • Prof. Dr. Manfred DöpfnercoreStrategic or Co-development PartnerFormer Head of AKiP Institute at University of Cologne, psychologist, psychotherapist, and author. Collaborated on evidence-based content development for VR ADHD therapy.
  • Fernuniversität HagenminorStrategic or Co-development PartnerResearch collaboration on BJ-103 VR Cochlea project for inner ear hearing loss treatment using VR technology.
  • _fbeta (Digital Health Consulting)minorStrategic or Co-development PartnerDigital health consulting partner. Jonas Albert, Partner at fbeta, serves on advisory board with expertise in DiGA/DiPA market. Member of DTx Consulting Alliance.
  • Kinder- und Jugendhilfe RegensburgminorImplementation/ SI/ Consulting PartnerChild and youth welfare organization in Regensburg. Clinical psychologist Julia Punk collaborates on therapy development and provides practical feedback from therapy settings.
  • Gallium StudiosminorStrategic or Co-development PartnerGaming expertise collaboration. Timothy Johnson, ex-Technical Director at WB Games (Harry Potter), Disney, serves as gaming expert on advisory board to ensure engaging gamification.

Scale indicators6 records

Recent moves4 records

Expansion highlights5 records

Brainjo competitors and assessment

Company assessment

Regional players

  • Selfapy: Selfapy is a Berlin-based DTx provider with DiGA-listed courses for depression, burnout and anxiety. It is a regional German competitor in the digital mental health reimbursement space adjacent to Brainjo's BJ-101, BJ-102 and BJ-104 assets.
  • HelloBetter: HelloBetter (formerly GET.ON) is a German digital therapeutics company with multiple DiGA-listed products for mental health. It is a direct regional peer in the German DiGA mental health category and a key competitor for physician adoption and reimbursement positioning.

Direct peers

  • BehaVR: BehaVR develops immersive VR-based digital therapeutics for behavioral and mental health conditions (anxiety, chronic pain, oncology support). It is a direct peer in VR-DTx modality and overlaps with Brainjo's anxiety (BJ-102) and chronic pain (BJ-108) pipeline assets.
  • Kaia Health: Kaia Health is a digital therapeutics company with DiGA-listed products in Germany for MSK pain and COPD. Advisory board member Dr. Stephan Huber is a former Kaia Health DTx expert, making Kaia both a direct DTx peer in Germany and an important prior employer signaling industry credibility.
  • Akili Interactive: Akili Interactive is a digital therapeutics company with an FDA-cleared prescription video game treatment (EndeavorRx) for pediatric ADHD. It is the closest direct competitor to Brainjo's BJ-101 VR HyperHero in indication, modality and patient age range, and represents the regulatory and commercial benchmark Brainjo is targeting via the DiGA pathway.
  • XRHealth: XRHealth operates a VR-based telehealth platform delivering clinician-supervised therapy for anxiety, ADHD, cognitive rehabilitation and pain — directly overlapping with Brainjo's clinical use cases and VR-modality approach.
  • Sympatient: Sympatient is a German startup offering VR-based exposure therapy for anxiety disorders and phobias, and is a DiGA-listed competitor. It is a direct regional peer to Brainjo's BJ-102 VR Phobien anxiety product in the German payer market.

Broad incumbents

  • Big Health: Big Health (Sleepio, Daylight) is a leading digital therapeutics company for insomnia and anxiety. It is a broader incumbent in prescription DTx for behavioral health and represents the scale-of-ambition benchmark Brainjo is targeting with its ADHD and anxiety assets.
  • Limbic: Limbic is a UK-based digital mental health platform with AI-driven support and is exploring VR-supported therapy. It is a broader incumbent in the European digital behavioral health space overlapping with Brainjo's BJ-101 and BJ-102.
  • MindMaze: MindMaze is a Swiss-based neurotechnology company building VR-based digital therapeutics for neurological and behavioral conditions. It is a broader incumbent in VR-DTx with significantly more capital and a multi-indication platform analogous to Brainjo's ambition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Brainjo social profiles

Digital presence

Brainjo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Brainjo leadership team

Management profile

Number of profiles

Profiles11 records

Brainjo funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Brainjo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brainjo

What does Brainjo do?

Brainjo develops VR-based digital therapeutics (DTx) — primarily the BJ-101 VR HyperHero program for children with ADHD (aged 8-13), with a pipeline of nine therapeutic candidates spanning phobias, depression, hearing loss, obesity, autism, cognitive decline, chronic pain and dialysis-related cognitive decline. In parallel, the company runs a Corporate Health division that sells VR BOX and VR HUB hardware bundles, delivers on-site corporate Health Day events, and licenses a 10-week Mental Fit corporate brain-training program combining cognitive and physical exercises.

Is Brainjo a public or private company?

Brainjo is a private company. It is classified as venture growth investor backed and is currently operating.

When was Brainjo founded?

Brainjo was founded in 2020. It employs 11 to 50 people.

Where is Brainjo based?

Brainjo is headquartered in Regensburg, Germany, in the Europe region.

How does Brainjo make money?

Five revenue lines are on record. VR BOX and VR HUB Hardware Sales are the primary driver. The others are health Day Events, enterprise Software Subscriptions, diGA (Digital Health Application) Revenue and corporate Health BGM Programs.

Who are Brainjo's main competitors?

Regional players on record are Selfapy and HelloBetter. Direct peers are BehaVR, Kaia Health, Akili Interactive, XRHealth and Sympatient. Broad incumbents are Big Health, Limbic and MindMaze.

Does Brainjo have an API?

No public API is recorded for Brainjo.

What industry is Brainjo in?

Brainjo's product category is Digital Therapeutics. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital). Its NAICS code is 54172 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
VentureRadarNew Funding Rounds in childrenMultiple startups involved in children-focused industries secured funding through various rounds, including MyVillage, brainjo, Sage Haven, Zūm, BIDSO, thelittleloop, Filli & Me, Little Kitchen Academy, and cadootz!. The funding amounts ranged from thousands to hundreds of millions of dollars, supporting developments in healthcare, education, safety, and consumer products for children.Pulse 2.0brainjo: €2 Million Seed Round To Advance VR-Based Digital Therapies For ADHDbrainjo GmbH has raised €2 million in seed funding to accelerate development of its virtual reality-based digital therapeutics for treating children with ADHD, with the round led by HTGF High-Tech Gründerfonds and participation from MEDICE – The Health Family and angel investors from better ventures. The funding will support regulatory approval efforts for the company's first VR-based Digital Health Application and enable commercialization across regulated healthcare markets. The raise reflects growing industry interest in immersive digital therapeutics as a solution to capacity constraints in mental healthcare, particularly for pediatric populations.EU-Startupsbrainjo raises €2 million to develop VR-based solutions that complement traditional therapy where it falls shortBrainjo, a Regensburg-based digital health startup, has closed a €2 million Seed funding round led by High-Tech Gründerfonds with participation from MEDICE – The Health Family and business angels. The funding will finance clinical studies and regulatory approval for the company's first VR-based digital therapy application for children with ADHD, with market approval planned for 2028. The company aims to complement traditional psychotherapy by offering immersive, individualised, and scalable therapy accessible from home.VestbeeBrainjo secures €2M to bring VR Therapy for children with ADHD to the digital health marketBrainjo, a Regensburg-based medtech firm, secured €2 million in seed funding led by High-Tech Gründerfonds to advance its VR-based digital therapeutic for children with ADHD. The funds will support clinical studies and regulatory approval as a German DiGA, enabling doctor prescription and insurance reimbursement. The company also has a pipeline for other conditions like phobias and depression.Tech.eubrainjo expands mental healthcare through VR and secures €2M in seed fundingbrainjo, a Regensburg-based digital health startup, closed a €2 million seed round led by High-Tech Gründerfonds. The funds will support a clinical study and regulatory approval of its first VR-based DiGA for children with ADHD, with market approval planned for 2028.Tech Funding NewsGerman startup brainjo raises €2M from HTGF to build prescribable VR therapy for children with ADHD — TFNBrainjo, a German startup, raised €2M in seed funding led by HTGF to develop a VR-based digital health app for children with ADHD. The company plans to list the app as a DiGA, Germany's prescribed digital health system, with market approval by 2028. A clinical study with about 100 children is underway.TechStartupsTop Startup and Tech Funding News – April 20 2025On April 20, 2026, multiple startups raised capital across AI, robotics, healthcare, and climate sectors. Recursive Superintelligence raised over $500M, X Square Robot raised $276M, and Pulnovo Medical raised $100M, with other rounds totaling over $400M. The funding reflects investor interest in AI systems operating in physical environments and applied AI in healthcare workflows.TechStartupsUber deepens bet on Delivery Hero in $318M deal amid EU merger pressure on ProsusUber agreed to buy an additional 4.5% stake in Delivery Hero from Prosus for about €270 million, paying €20 per share. The deal reduces Prosus's stake to roughly 21% and is tied to EU approval of its €4.1 billion Just Eat acquisition. Uber's growing stake signals confidence in Delivery Hero's scale model amid shifting European merger rules.FinSMEsbrainjo Raises €2M in Seed Fundingbrainjo, a Regensburg-based VR mental healthcare company, raised €2M in seed funding led by High-Tech Gründerfonds. The company will use the funds to expand operations and development, and is about to launch its first clinical study.